242 related articles for article (PubMed ID: 25919161)
21. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
22. Vaccination planning in Italy: increasing vaccines while reducing coverage?
Garattini L; Curto A; Freemantle N
Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):547-548. PubMed ID: 27441592
[No Abstract] [Full Text] [Related]
23. Costs and financing of routine immunization: Approach and selected findings of a multi-country study (EPIC).
Brenzel L; Young D; Walker DG
Vaccine; 2015 May; 33 Suppl 1():A13-20. PubMed ID: 25919153
[TBL] [Abstract][Full Text] [Related]
24. Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania.
Mvundura M; Lorenson K; Chweya A; Kigadye R; Bartholomew K; Makame M; Lennon TP; Mwangi S; Kirika L; Kamau P; Otieno A; Murunga P; Omurwa T; Dafrossa L; Kristensen D
Vaccine; 2015 May; 33(23):2697-703. PubMed ID: 25865467
[TBL] [Abstract][Full Text] [Related]
25. A comparative cost analysis of the Vaccination Program for US-bound Refugees.
Joo H; Maskery B; Mitchell T; Leidner A; Klosovsky A; Weinberg M
Vaccine; 2018 May; 36(20):2896-2901. PubMed ID: 28919225
[TBL] [Abstract][Full Text] [Related]
26. Systematic review of economic evaluation studies: are vaccination programs efficient in Spain?
García-Altés A
Vaccine; 2013 Mar; 31(13):1656-65. PubMed ID: 23370153
[TBL] [Abstract][Full Text] [Related]
27. Enlarged free childhood vaccination offer in Italy proposed to curb the rise in the growing anti-vaccine message.
Bonanni P
Expert Rev Vaccines; 2018 Feb; 17(2):103-105. PubMed ID: 29257703
[No Abstract] [Full Text] [Related]
28. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
[TBL] [Abstract][Full Text] [Related]
29. Tracking financial flows for immunization in Honduras.
Valdés W; Janusz CB; Molina Aguilera IB; Mendoza L; Díaz IY; Resch S
Vaccine; 2015 May; 33 Suppl 1():A85-92. PubMed ID: 25919182
[TBL] [Abstract][Full Text] [Related]
30. The decision making process on new vaccines introduction in South Africa.
Ngcobo NJ; Cameron NA
Vaccine; 2012 Sep; 30 Suppl 3():C9-13. PubMed ID: 22939028
[TBL] [Abstract][Full Text] [Related]
31. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
[TBL] [Abstract][Full Text] [Related]
32. Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization.
Jit M; Dang TT; Friberg I; Hoang VM; Pham Huy TK; Walker N; Nguyen VC; Tran ND; Toda K; Hutubessy R; Fox K; Nguyen TH
Vaccine; 2015 May; 33 Suppl 1(Suppl 1):A233-9. PubMed ID: 25919167
[TBL] [Abstract][Full Text] [Related]
33. Costs of routine immunization and the introduction of new and underutilized vaccines in Ghana.
Le Gargasson JB; Nyonator FK; Adibo M; Gessner BD; Colombini A
Vaccine; 2015 May; 33 Suppl 1():A40-6. PubMed ID: 25919173
[TBL] [Abstract][Full Text] [Related]
34. An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh.
Levin A; Levin C; Kristensen D; Matthias D
Vaccine; 2007 Sep; 25(39-40):6945-57. PubMed ID: 17707556
[TBL] [Abstract][Full Text] [Related]
35. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
[TBL] [Abstract][Full Text] [Related]
36. Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine Introduction.
Shen AK; Weiss JM; Andrus JK; Pecenka C; Atherly D; Taylor K; McQuestion M
Health Aff (Millwood); 2016 Feb; 35(2):272-6. PubMed ID: 26858380
[TBL] [Abstract][Full Text] [Related]
37. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.
Gandhi G; Lydon P; Cornejo S; Brenzel L; Wrobel S; Chang H
Vaccine; 2013 Apr; 31 Suppl 2():B137-48. PubMed ID: 23598475
[TBL] [Abstract][Full Text] [Related]
38. Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.
Knobler S; Bok K; Gellin B
Vaccine; 2017 Jan; 35 Suppl 1():A43-A45. PubMed ID: 28017435
[TBL] [Abstract][Full Text] [Related]
39. Financing vaccines for adolescents: a position paper of the society for adolescent health and medicine.
Kharbanda EO; Lee GM; Koenigs L;
J Adolesc Health; 2011 Mar; 48(3):320-1. PubMed ID: 21338909
[TBL] [Abstract][Full Text] [Related]
40. [Vaccines: building on scientific excellence and dispelling false myths].
Signorelli C
Epidemiol Prev; 2015; 39(3):198-201. PubMed ID: 26522283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
